<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/rgen" ></link>
<id>urn:uuid:18f1ec09-6282-7f44-d373-fe7f907c429f</id>
<updated>2026-04-22T03:33:05-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>RGEN: KURIYEL RALF (VP) Acquired (JB) 5,284 Shares of REPLIGEN CORP for $0.00 on 3/5</title>
<link href="http://www.insiderinsights.com/company/rgen/repligen-corp/id-6371325" ></link>
<id>urn:uuid:c089ece4-ec66-20fc-6c19-395e76f8d91a</id>
<updated>2026-03-23T12:00:33-04:00</updated>
<summary type="html" ><![CDATA[REPLIGEN CORP (RGEN). Recent Price: $131.21. Mkt Cap:7.4B. 10D Vol: 783,100]]></summary>
</entry>
<entry>
<title>RGEN: LOEILLOT OLIVIER (CEO) Acquired (JB) 24,134 Shares of REPLIGEN CORP for $0.00 on 3/5</title>
<link href="http://www.insiderinsights.com/company/rgen/repligen-corp/id-6371318" ></link>
<id>urn:uuid:b2ce0f08-148a-802a-c117-d8ecb97ceba0</id>
<updated>2026-03-23T11:53:49-04:00</updated>
<summary type="html" ><![CDATA[REPLIGEN CORP (RGEN). Recent Price: $131.21. Mkt Cap:7.4B. 10D Vol: 783,100]]></summary>
</entry>
<entry>
<title>RGEN: BYLUND JAMES (COO) Acquired (JB) 7,751 Shares of REPLIGEN CORP for $0.00 on 3/5</title>
<link href="http://www.insiderinsights.com/company/rgen/repligen-corp/id-6371317" ></link>
<id>urn:uuid:2b5f5809-99f8-fa8a-4db1-5e3b9f4974f2</id>
<updated>2026-03-23T11:53:02-04:00</updated>
<summary type="html" ><![CDATA[REPLIGEN CORP (RGEN). Recent Price: $131.21. Mkt Cap:7.4B. 10D Vol: 783,100]]></summary>
</entry>
<entry>
<title>RGEN: GARLAND JASON K (CFO) Acquired (JB) 7,751 Shares of REPLIGEN CORP for $0.00 on 3/5</title>
<link href="http://www.insiderinsights.com/company/rgen/repligen-corp/id-6371314" ></link>
<id>urn:uuid:d797f75f-2c4b-9995-72ad-1d5a1e3b8690</id>
<updated>2026-03-23T11:51:37-04:00</updated>
<summary type="html" ><![CDATA[REPLIGEN CORP (RGEN). Recent Price: $131.21. Mkt Cap:7.4B. 10D Vol: 783,100]]></summary>
</entry>
<entry>
<title>RGEN: BYLUND JAMES (COO) Acquired (JB) 125 Shares of REPLIGEN CORP for $0.00 on 3/4</title>
<link href="http://www.insiderinsights.com/company/rgen/repligen-corp/id-6352897" ></link>
<id>urn:uuid:4af38cfc-3993-f4e4-ef5a-76357f271571</id>
<updated>2026-03-05T13:28:48-05:00</updated>
<summary type="html" ><![CDATA[REPLIGEN CORP (RGEN). Recent Price: $131.21. Mkt Cap:7.4B. 10D Vol: 783,100]]></summary>
</entry>
<entry>
<title>RGEN: BYLUND JAMES (COO) Disposed (JS) 62 Shares of REPLIGEN CORP for $125.84 on 3/4</title>
<link href="http://www.insiderinsights.com/company/rgen/repligen-corp/id-6352898" ></link>
<id>urn:uuid:95859bc8-2219-42f5-b734-10a35eee406c</id>
<updated>2026-03-05T13:28:48-05:00</updated>
<summary type="html" ><![CDATA[REPLIGEN CORP (RGEN). Recent Price: $131.21. Mkt Cap:7.4B. 10D Vol: 783,100]]></summary>
</entry>
<entry>
<title>RGEN: KURIYEL RALF (VP) Acquired (JB) 125 Shares of REPLIGEN CORP for $0.00 on 3/4</title>
<link href="http://www.insiderinsights.com/company/rgen/repligen-corp/id-6352895" ></link>
<id>urn:uuid:dc291a83-ce9e-906b-467e-f1b545f61f25</id>
<updated>2026-03-05T13:25:03-05:00</updated>
<summary type="html" ><![CDATA[REPLIGEN CORP (RGEN). Recent Price: $131.21. Mkt Cap:7.4B. 10D Vol: 783,100]]></summary>
</entry>
<entry>
<title>RGEN: KURIYEL RALF (VP) Disposed (JS) 42 Shares of REPLIGEN CORP for $125.84 on 3/4</title>
<link href="http://www.insiderinsights.com/company/rgen/repligen-corp/id-6352896" ></link>
<id>urn:uuid:3cfcd3b8-6293-622d-7815-48c2175dae7d</id>
<updated>2026-03-05T13:25:03-05:00</updated>
<summary type="html" ><![CDATA[REPLIGEN CORP (RGEN). Recent Price: $131.21. Mkt Cap:7.4B. 10D Vol: 783,100]]></summary>
</entry>
<entry>
<title>RGEN: BYLUND JAMES (COO) Disposed (JS) 3,911 Shares of REPLIGEN CORP for $124.97 on 2/27-3/2</title>
<link href="http://www.insiderinsights.com/company/rgen/repligen-corp/id-6346399" ></link>
<id>urn:uuid:341a5f0b-55a5-7e7e-b150-74ed453ed0eb</id>
<updated>2026-03-03T14:02:34-05:00</updated>
<summary type="html" ><![CDATA[REPLIGEN CORP (RGEN). Recent Price: $131.21. Mkt Cap:7.4B. 10D Vol: 783,100]]></summary>
</entry>
<entry>
<title>RGEN: LOEILLOT OLIVIER (CEO,DIR) Disposed (JS) 1,954 Shares of REPLIGEN CORP for $124.97 on 2/27-3/2</title>
<link href="http://www.insiderinsights.com/company/rgen/repligen-corp/id-6346368" ></link>
<id>urn:uuid:3fc018bb-42c0-9b6e-eb75-07ce65c6b58d</id>
<updated>2026-03-03T13:39:26-05:00</updated>
<summary type="html" ><![CDATA[REPLIGEN CORP (RGEN). Recent Price: $131.21. Mkt Cap:7.4B. 10D Vol: 783,100]]></summary>
</entry>
</feed>